Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From compliance to prediction: Clinical Laboratories as digital infrastructure for health-system quality and safety.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2026

Same author

Deep learning in image forgery: A systematic review for risk of bias (RoB).

Journal of forensic sciences·2026

Same author

The Practice of Cytopathology in India: Insights From a 2025 Nationwide Survey.

Diagnostic cytopathology·2026

Same author

Targeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancer.

Cancer immunology research·2026

Same author

Transposable element small RNAs and large RNAs in aging brains and implications in Huntington's and Parkinson's disease.

Genome research·2026

Same author

Programmable Poly-Lactic-Co-Glycolic Acid Nanocarriers for Precision Therapy of Pancreatic Ductal Adenocarcinoma.

Drug development research·2026

Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026

Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026

Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026

Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026

Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026

Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

TPP-based conjugates: potential targeting ligands.

Sanya Batheja¹, Shruti Gupta², Kiran Kumar Tejavath³

¹Nanopolymeric Drug Delivery Lab, Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, NH-8, Bandarsindri, Kishangarh, Ajmer 305817, India.

Drug Discovery Today

|April 19, 2024

Summary

This summary is machine-generated.

Triphenylphosphonium (TPP) conjugates target cancer cell mitochondria, offering therapeutic potential for various diseases. These TPP-based agents show promise in targeted drug delivery systems by modulating cellular energy metabolism.

More Related Videos

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Related Experiment Videos

Last Updated: Jun 28, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Area of Science:

Biochemistry
Oncology
Pharmacology

Background:

Mitochondria are crucial for cancer cell energy and metabolism.
Mitochondria are key targets for cancer treatment.
Triphenylphosphonium (TPP) derivatives show promise for cancer targeting due to lipophilicity and mitochondrial affinity.

Purpose of the Study:

To review the utility of TPP-based conjugates targeting mitochondria.
To explore their application in cancer and other diseases like neurodegenerative and cardiovascular disorders.
To highlight TPP conjugates as potential agents for targeted drug delivery.

Main Methods:

Literature review of TPP-based conjugates.
Analysis of TPP conjugates' mechanisms of action.
Summary of therapeutic applications in various diseases.

Main Results:

TPP conjugates effectively target mitochondria.
These conjugates modulate mitochondrial membrane potential and reactive oxygen species (ROS) production.
TPP conjugates influence ATP and energy metabolism.

Conclusions:

TPP conjugates are versatile therapeutic agents.
They offer significant potential for targeted drug delivery systems.
TPP conjugates represent a promising strategy for treating cancer and other diseases by targeting mitochondria.